Neurodevelopmental Disorders and Anti-Epileptic Treatment in a Patient with a SATB1 Mutation: A Case Report.

Ying Yu,Cuiyun Li,Wei Li,Liting Chen,Dan Wang,Jie Wang,Jian Wang,Ruen Yao
DOI: https://doi.org/10.3389/fped.2022.931667
IF: 3.569
2022-01-01
Frontiers in Pediatrics
Abstract:SATB1 variants causing developmental delay with dysmorphic facies and dental anomalies have been reported in a small cohort. Most patients present epilepsy as a main clinical feature in neurodevelopmental disorders; however, its treatment is unknown. Here, we present a Chinese patient with a de novo truncating variation in SATB1 who presented with mild developmental delay. We disclose the detailed anti-epileptic pharmacological treatment that enabled a favorable outcome. Our study provides important information that may aid clinicians in the prognosis and treatment of rare neurological developmental disorders caused by gene mutations.
What problem does this paper attempt to address?